Watch Ticker

Biogen Inc. Common Stock

Go to Biogen Inc. Common Stock Website

$132.98

1.03 (0.78%)

Live

Previous Close

$131.95

Day Range

$130.39 - $133.98

Previous Day Range

$124.5561 - $132.9

Market Cap

$19.3 billion USD

Day Vol.

1.9 million

Previous Day Vol.

2.8 million

Currency

USD

Primary Exchange

Nasdaq

Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva (oncology) and Ocrevus (multiple sclerosis) are marketed via a colla...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Vandana Singh - Biogen Lifts Outlook As Rare Disease And Alzheimer's Drug Sales Accelerate

Biogen reported strong Q2 2025 earnings, with EPS of $5.47 beating estimates and sales rising 7% to $2.65 billion. The company raised its full-year earnings guidance and saw growth in Alzheimer's drug Leqembi and rare disease treatments.

Related tickers: BIIB, NVS.

Read Full Article

Eisai And Biogen - Two-Year Real-World Study of LEQEMBI® in the United States Presented at Alzheimer's Association International Conference (AAIC) 2025

A two-year real-world study of lecanemab for early Alzheimer's disease was presented at AAIC 2025, showing promising results with 83.6% of patients remaining stable or improving clinically, and generally positive safety outcomes.

Related tickers: ESAIY, BIIB.

Read Full Article

Trending Tickers

Please sign in to view